Yonhap Infomax NewsHanmi Pharmaceutical is expected to post solid Q2 results despite seasonal headwinds, with high-margin product sales offsetting weak API exports and subsidiary performance.
#YonhapInfomax #HanmiPharmaceutical #Q2Earnings #OperatingProfit #Rosuzet #Amozaltan #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=73062
#YonhapInfomax #HanmiPharmaceutical #Q2Earnings #OperatingProfit #Rosuzet #Amozaltan #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=73062
Hanmi Pharmaceutical Expected to Deliver Solid Q2 Results Despite Off-Season—'High-Margin Product Sales Drive Performance'
Hanmi Pharmaceutical is expected to post solid Q2 results despite seasonal headwinds, with high-margin product sales offsetting weak API exports and subsidiary performance.